Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
AD-PluReceptor + Tafasitamab for Autoimmune Disorders
Recruiting1 awardPhase 1 & 2
Houston, Texas
"This trial is first testing the safety of tafasitamab in patients with certain diseases. Then, it will determine the best dose of a combination treatment involving AD-PluReceptor-N
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service